Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab (Herceptin) as adjuvant treatment in early operable HER2-positive breast cancer – Phase IV Danish population-based study
2005-005433-35Phase 4Completed
- Sponsor
- Danish Breast Cancer Cooperative Group
- Start
- Aug 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of trastuzumab in breast cancer, sponsored by Danish Breast Cancer Cooperative Group. Primary endpoint: Symptomatic heart disease incidence and course. Started Aug 2008; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-005433-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005433-35.